This is the authors' abstract. We don't add key points for this paper.
A new fluorinated silicon reagent bearing a functionalized tetrafluoroethylene fragment was prepared from two CF 2 building blocks: ethyl bromodifluoroacetate and (bromodifluoromethyl)trimethylsilane. The key C–C bond-forming step involves a difluorocarbene addition/cyclopropane rearrangement sequence. The silicon reagent was coupled with aldehydes and reactive azomethines in the presence of potassium fluoride.
No takes yet. Share an insight, caveat, or question.
Fedorov et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: